Developing CAR T Cells for Cancer
Crystal Mackall - Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and of Medicine
Bio-X Affiliated Faculty
Dr. Mackall is an expert in the field of T cell homeostasis, and her group was one of the first to demonstrate the success of a cancer therapy for pediatric acute lymphoblastic leukemia that works by modifying the patient’s own immune cells.
Research News
CAR-T cell therapy for cancer causes ‘brain fog,’ Stanford Medicine-led study shows
May 12, 2025 - Stanford Medicine News Center
Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, Stanford...
A new RNA editing tool could enhance cancer treatment
February 21, 2024 - Stanford News
The new study from Stanford Bio-X affiliated faculty members Stanley Qi and Crystal Mackall and Stanford Bio-X...
Stanford engineers develop a simple delivery method that enhances a promising cancer treatment
April 8, 2022 - Stanford News
Stanford Bio-X affiliated faculty members Eric Appel, Crystal Mackall, Ovijit Chaudhuri, and Jennifer Cochran,...